Reuters logo
BRIEF-Zynerba Pharmaceuticals reports Q1 loss per share $0.60
2017年5月9日 / 中午11点49分 / 4 个月前

BRIEF-Zynerba Pharmaceuticals reports Q1 loss per share $0.60

May 9 (Reuters) - Zynerba Pharmaceuticals Inc:

* Zynerba Pharmaceuticals reports first quarter 2017 financial results and operational highlights

* Q1 loss per share $0.60

* Q1 earnings per share view $-0.55 -- Thomson Reuters I/B/E/S

* Zynerba Pharmaceuticals Inc - believes that current cash position of $77.5 million is sufficient to fund operations and capital requirements into 2019 Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below